Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
06/07/2001 | CA2392853A1 Hbv sequences |
06/07/2001 | CA2392762A1 Method for producing adherent animal cells |
06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
06/07/2001 | CA2392534A1 Method and apparatus for selectively targeting specific cells within a cell population |
06/07/2001 | CA2391404A1 Udp-glucose:aglycon-glucosyltransferase |
06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
06/06/2001 | EP1104887A2 A method and test kit for assaying collagen fragments in body fluids |
06/06/2001 | EP1104808A1 ESTs and encoded human proteins |
06/06/2001 | EP1104769A2 Modified green fluorescent proteins |
06/06/2001 | EP1104492A1 Subtle mitochondrial mutations as tumor markers |
06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
06/06/2001 | EP1104480A1 Polynucleotide sequences |
06/06/2001 | EP1104477A1 Increasing stearate content in soybean oil by expression of acyl-acp thioesterase |
06/06/2001 | EP1104476A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
06/06/2001 | EP1104474A1 Dna constructs comprising protease encoding sequences or inhibitors thereof |
06/06/2001 | EP1104473A2 Proteases and associated proteins |
06/06/2001 | EP1104472A1 Gene switch |
06/06/2001 | EP1104471A2 Pesticidal toxins and genes from bacillus laterosporus strains |
06/06/2001 | EP1104470A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
06/06/2001 | EP1104468A1 Genetic method for the expression of polyproteins in plants |
06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
06/06/2001 | EP1104459A1 Dna shuffling of monooxygenase genes for production of industrial chemicals |
06/06/2001 | EP1104457A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
06/06/2001 | EP1104455A2 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
06/06/2001 | EP1104231A1 Biodegradable high oxidative stability oils |
06/06/2001 | EP0907312A4 Compositions and methods for taxol biosynthesis |
06/06/2001 | EP0804457B1 Modified green fluorescenct proteins |
06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
06/06/2001 | EP0579626B1 Method and agents for promoting wound healing |
06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
06/06/2001 | CN1298451A Adenoviral vectors for treating disease |
06/06/2001 | CN1298449A Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase |
06/06/2001 | CN1298447A Biosynthetic genes for spinosyn insecticide production |
06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
06/06/2001 | CN1298411A Caspase-8 interacting proteins |
06/06/2001 | CN1298308A Inhibitors of complement activation |
06/06/2001 | CN1066731C Substrates for beta-lactamase and uses thereof |
06/06/2001 | CA2291367A1 Genetic constructions having a reduced or an increased number of epigenetic control regions and methods of use thereof |
06/05/2001 | US6242669 Pesticidal toxins and nucleotide sequences which encode these toxins |
06/05/2001 | US6242666 Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
06/05/2001 | US6242586 Amino acid sequence of t cell surface antigen; fusion proteins; treatment of autoimmune diseases; antiarthritic agents; antiinflammatory agents; immunosuppressants; diagnosis; recombinant production |
06/05/2001 | US6242579 Antigen found on a small subset of human hematopoietic cells which binds to monoclonal antibody MG1 |
06/05/2001 | US6242575 Antibodies for detecting p27 protein |
06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
06/05/2001 | US6242417 Stabilized compositions containing hemoglobin |
06/05/2001 | US6242259 Compositions and methods for packing of alphavirus vectors |
06/05/2001 | US6242257 Tissue culture process for producing a large number of viable cotton plants in vitro |
06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
06/05/2001 | US6242254 Cell has dna encoding tetracycline responsive transcriptional activator linked to tissue-specific promoter and tetracycline operator minimal promoter linked to dna encoding sv40 t antigen; cell proliferation is controlled by tetracycline |
06/05/2001 | US6242252 Hepatic progenitors and method of isolating same |
06/05/2001 | US6242251 Polynucleotide which codes for polypeptide receptor of defined amino acid sequence having affinity for neuropeptide y, pancreatic polypeptide, or peptide yy; transfected host cells; drug screening |
06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
06/05/2001 | US6242247 Device for in vitro production includes space for receiving cells and culture medium and that has semipermeable or porous walls, and means for positioning and immersing cell space in culture medium; one wall is bone substitute plate |
06/05/2001 | US6242241 Nucleotide and amino acid sequences; transgenic plants; transformed host cells |
06/05/2001 | US6242218 Dna construct for altering gene expression of endogenous granulocyte-colony stimulating factor in mammalian cell; gene therapy; culture production |
06/05/2001 | US6242213 Nucleotide sequences coding preferential polypeptide for use in controlling immune response |
06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
06/05/2001 | US6242211 Methods for generating and screening novel metabolic pathways |
06/05/2001 | US6242204 Methods of detecting non-small cell lung carcinoma and ovarian cancer |
06/05/2001 | US6242183 Interaction trap systems for detecting protein interactions |
06/05/2001 | US6242179 Nucleotide sequences coding eukaryotic hydrolase; for the diagnosis, prevention, and treatment of immune defects and cancers; anticarcinogenic agents |
06/05/2001 | US6241991 Aviadenovirus |
06/05/2001 | US6241986 Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV |
06/05/2001 | US6241984 Human hematopoietic progenitor cell preparations and their expansion in a liquid medium |
06/05/2001 | US6241982 Method for treating brain cancer with a conditionally lethal gene |
06/05/2001 | US6241981 Composition and method for repairing neurological tissue |
06/05/2001 | US6240926 Compositions and methods for intervertebral disc reformation |
06/05/2001 | CA2124937C T-pa substitution variants with improved fibrin-specificity |
06/05/2001 | CA2112408C Monoclonal antibody to lymphocyte-associated cell surface protein |
06/05/2001 | CA1341246C Somatic cell gene therapy |
06/05/2001 | CA1341242C Dna sequence, vectors, recombinant viruses, and process involving recombinant cowpox viruses capable of multiplying in cho cells |
06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
05/31/2001 | WO2001038876A1 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein |
05/31/2001 | WO2001038872A2 Assay of isomerised and/or optically inverted proteins |
05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
05/31/2001 | WO2001038531A1 Human nucleoprotein having www domain and polynucleotide encoding the same |
05/31/2001 | WO2001038518A1 Promoter and intron from maize actin depolymerizing factor |
05/31/2001 | WO2001038517A1 Gene expressing protein capable of capturing metal |
05/31/2001 | WO2001038514A2 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams |
05/31/2001 | WO2001038511A2 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
05/31/2001 | WO2001038509A1 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
05/31/2001 | WO2001038507A1 Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene |